Diebold Nixdorf Inc DBD.N, DBD is expected to show a fall in quarterly revenue when it reports results on February 12 for the period ending December 31 2024
The North Canton Ohio-based company is expected to report a 4.8% decrease in revenue to $987.768 million from $1.04 billion a year ago, according to the mean estimate from 2 analysts, based on LSEG data.
LSEG's mean analyst estimate for Diebold Nixdorf Inc is for earnings of $1.05 per share.
The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Diebold Nixdorf Inc is $62.50, above its last closing price of $44.54.
This summary was machine generated February 10 at 13:43 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)